Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.

Cancer - 1 Jun 2010

Cortot Alexis B, Italiano Antoine, Burel-Vandenbos Fanny, Martel-Planche Ghyslaine, Hainaut Pierre

Abstract excerpt

BACKGROUND: The objective of this study was to determine whether the mutation status of the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal growth factor receptor (EGFR) differed between primary tumors and matched distant metastases in nonsmall cell lung cancer (NSCLC). METHODS: Patients who underwent resection for both primary NSCLC and matched distant metastases were included in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Genes, ras

Share to Lung Neoplasms

Share to Mutation

Share to Neoplasm Metastasis

Source

Identifiers

PMID: 20336783
DOI: 10.1002/cncr.25014

Genes

KRAS
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.PMID 20336783Read ↗

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.Semantic proximity Read ↗

EGFR and KRAS mutations in metastatic lung adenocarcinomas.Semantic proximity Read ↗

Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.Semantic proximity Read ↗

[Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].Semantic proximity Read ↗

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.Semantic proximity Read ↗

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.Semantic proximity Read ↗

Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer.Semantic proximity Read ↗

EGFR mutations, gene amplification, and protein expression and KRAS mutations in primary and metastatic tumors of nonsmall cell lung cancers and their clinical implications: a meta-analysis.Semantic proximity Read ↗

EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.Semantic proximity Read ↗

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.Semantic proximity Read ↗

Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.Semantic proximity Read ↗

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.